New Zealand markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
89.99+0.17 (+0.19%)
At close: 04:00PM EST
90.16 +0.17 (+0.19%)
After hours: 07:49PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 191.63B
Enterprise value 201.07B
Trailing P/E 9.01
Forward P/E 13.72
PEG ratio (5-yr expected) 5.45
Price/sales (ttm)3.71
Price/book (mrq)3.09
Enterprise value/revenue 3.85
Enterprise value/EBITDA 6.45

Trading information

Stock price history

Beta (5Y monthly) 0.51
52-week change 311.54%
S&P500 52-week change 3-11.22%
52-week high 394.26
52-week low 374.09
50-day moving average 380.36
200-day moving average 384.45

Share statistics

Avg vol (3-month) 32.33M
Avg vol (10-day) 31.74M
Shares outstanding 52.15B
Implied shares outstanding 6N/A
Float 82.06B
% held by insiders 10.01%
% held by institutions 18.47%
Shares short (14 Nov 2022) 45.26M
Short ratio (14 Nov 2022) 42.33
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.24%
Shares short (prior month 13 Oct 2022) 46.08M

Dividends & splits

Forward annual dividend rate 43.33
Forward annual dividend yield 43.81%
Trailing annual dividend rate 33.39
Trailing annual dividend yield 33.77%
5-year average dividend yield 43.53
Payout ratio 434.28%
Dividend date 316 Mar 2022
Ex-dividend date 407 Mar 2022
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 41.71%
Operating margin (ttm)27.17%

Management effectiveness

Return on assets (ttm)7.41%
Return on equity (ttm)36.99%

Income statement

Revenue (ttm)52.26B
Revenue per share (ttm)23.68
Quarterly revenue growth (yoy)-3.90%
Gross profit (ttm)37.44B
Net income avi to common (ttm)21.8B
Diluted EPS (ttm)9.94
Quarterly earnings growth (yoy)-43.00%

Balance sheet

Total cash (mrq)19.01B
Total cash per share (mrq)8.84
Total debt (mrq)28.54B
Total debt/equity (mrq)46.86
Current ratio (mrq)1.31
Book value per share (mrq)28.27

Cash flow statement

Operating cash flow (ttm)14.01B
Levered free cash flow (ttm)13B